Real-world risk of diabetes with second-generation antipsychotics in older people

Prasad Nishtala; Te yuan Chyou

Real-world risk of diabetes with second-generation antipsychotics in older people

University of Otago

Research output: Chapter or section in a book/report/conference proceeding › Chapter in a published conference proceeding

Original language	English
Title of host publication	Proceedings of the International Society for Pharmacologepidemiology (ISPE) 32nd International Conference on Pharmacopepidemiology & Therapeutic Risk Management
Publisher	ISPE
Publication status	Published - 31 Dec 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

http://www.abstracts2view.com/ispe/view.php?nu=ISPE16L1_267

Cite this

Real-world risk of diabetes with second-generation antipsychotics in older people. / Nishtala, Prasad; Chyou, Te yuan.
Proceedings of the International Society for Pharmacologepidemiology (ISPE) 32nd International Conference on Pharmacopepidemiology & Therapeutic Risk Management. ISPE, 2016. 617.

Research output: Chapter or section in a book/report/conference proceeding › Chapter in a published conference proceeding

@inproceedings{6b90823f9acd4356b276b36545e218b1,

title = "Real-world risk of diabetes with second-generation antipsychotics in older people",

author = "Prasad Nishtala and Chyou, \{Te yuan\}",

year = "2016",

month = dec,

day = "31",

language = "English",

booktitle = "Proceedings of the International Society for Pharmacologepidemiology (ISPE) 32nd International Conference on Pharmacopepidemiology \& Therapeutic Risk Management",

publisher = "ISPE",

}

TY - GEN

T1 - Real-world risk of diabetes with second-generation antipsychotics in older people

AU - Nishtala, Prasad

AU - Chyou, Te yuan

PY - 2016/12/31

Y1 - 2016/12/31

M3 - Chapter in a published conference proceeding

BT - Proceedings of the International Society for Pharmacologepidemiology (ISPE) 32nd International Conference on Pharmacopepidemiology & Therapeutic Risk Management

PB - ISPE

ER -